BioVie Inc. (BIVI)
NASDAQ: BIVI · IEX Real-Time Price · USD
0.500
+0.007 (1.40%)
May 2, 2024, 4:00 PM EDT - Market closed
BIVI's stock price has decreased by -93.21% in the past year and price targets may not have had time to catch up.
BioVie Analyst Ratings
Total Analysts
2
Consensus Rating
Buy
Price Target
$8.00
Upside
+1,500.32%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $12 → $5 | Buy | Maintains | $12 → $5 | +900.20% | Nov 30, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $11 | Buy | Reiterates | $11 | +2,100.44% | Aug 22, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $11 | Buy | Reiterates | $11 | +2,100.44% | Jul 18, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $11 | Buy | Reiterates | $11 | +2,100.44% | May 17, 2023 |
| Oppenheimer | Oppenheimer | Buy Reiterates $12 | Buy | Reiterates | $12 | +2,300.48% | May 17, 2023 |
| Oppenheimer | Oppenheimer | Buy Reiterates $12 | Buy | Reiterates | $12 | +2,300.48% | Feb 14, 2023 |
| EF Hutton | EF Hutton | Strong Buy Maintains $14 → $8 | Strong Buy | Maintains | $14 → $8 | +1,500.32% | Sep 28, 2022 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $7 | Buy | Initiates | $7 | +1,300.28% | Jul 22, 2022 |
| EF Hutton | EF Hutton | Strong Buy Maintains $9 → $14 | Strong Buy | Maintains | $9 → $14 | +2,700.56% | Mar 17, 2022 |
| Oppenheimer | Oppenheimer | Buy Initiates $9 | Buy | Initiates | $9 | +1,700.36% | Mar 15, 2022 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Nov 30, 2021 |